+ Follow IAN READ Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1525356
[Title] => Pfizer, Allergan $160B deal forms world's largest drugmaker
[Summary] => Pfizer and Allergan are joining in the biggest buyout of the year, a $160 billion stock deal that will create the world's largest drugmaker.
[DatePublished] => 2015-11-23 07:47:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
[1] => Array
(
[ArticleID] => 636390
[Title] => Pfizer CEO Jeffrey Kindler steps down unexpectedly
[Summary] => Jeffrey B. Kindler, the CEO of the world's biggest drugmaker, stepped down Sunday unexpectedly — after less than five years heading Pfizer Inc., a period in which he reorganized most of the company's operations and made an imprint on the industry.
[DatePublished] => 2010-12-06 10:49:11
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] =>
[SectionUrl] =>
[URL] =>
)
)
)
IAN READ
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1525356
[Title] => Pfizer, Allergan $160B deal forms world's largest drugmaker
[Summary] => Pfizer and Allergan are joining in the biggest buyout of the year, a $160 billion stock deal that will create the world's largest drugmaker.
[DatePublished] => 2015-11-23 07:47:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
[1] => Array
(
[ArticleID] => 636390
[Title] => Pfizer CEO Jeffrey Kindler steps down unexpectedly
[Summary] => Jeffrey B. Kindler, the CEO of the world's biggest drugmaker, stepped down Sunday unexpectedly — after less than five years heading Pfizer Inc., a period in which he reorganized most of the company's operations and made an imprint on the industry.
[DatePublished] => 2010-12-06 10:49:11
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] =>
[SectionUrl] =>
[URL] =>
)
)
)
abtest
November 23, 2015 - 7:47am
December 6, 2010 - 10:49am